Sighpath Pharma Inc.
1Patents
1Active
1Granted
42Portfolio score
Filing activity: Jan 11, 2017 → Jan 11, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10349884B2 | Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel | Human Necessities | 15 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.